| Veröffentlichte Version Download ( PDF | 1MB) | Lizenz: Creative Commons Namensnennung 4.0 International |
Expression of pH-Sensitive GPCRs in Peritoneal Carcinomatosis of Colorectal Cancer—First Results
von Breitenbuch, Philipp, Kurz, Bernadett, Wallner, Susanne, Zeman, Florian
, Brochhausen, Christoph
, Schlitt, Hans-Jürgen und Schreml, Stephan
(2023)
Expression of pH-Sensitive GPCRs in Peritoneal Carcinomatosis of Colorectal Cancer—First Results.
Journal of Clinical Medicine 12 (5), S. 1803.
Veröffentlichungsdatum dieses Volltextes: 06 Mrz 2023 16:28
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.53899
Zusammenfassung
Solid tumors have an altered metabolism with a so-called inside-out pH gradient (decreased pH(e) < increased pH(i)). This also signals back to tumor cells via proton-sensitive ion channels or G protein-coupled receptors (pH-GPCRs) to alter migration and proliferation. Nothing, however, is known about the expression of pH-GPCRs in the rare form of peritoneal carcinomatosis. Paraffin-embedded ...
Solid tumors have an altered metabolism with a so-called inside-out pH gradient (decreased pH(e) < increased pH(i)). This also signals back to tumor cells via proton-sensitive ion channels or G protein-coupled receptors (pH-GPCRs) to alter migration and proliferation. Nothing, however, is known about the expression of pH-GPCRs in the rare form of peritoneal carcinomatosis. Paraffin-embedded tissue samples of a series of 10 patients with peritoneal carcinomatosis of colorectal (including appendix) origin were used for immunohistochemistry to study the expression of GPR4, GPR65, GPR68, GPR132, and GPR151. GPR4 was just expressed weakly in 30% of samples and expression was significantly reduced as compared to GPR56, GPR132, and GPR151. Furthermore, GPR68 was only expressed in 60% of tumors and showed significantly reduced expression as compared to GPR65 and GPR151. This is the first study on pH-GPCRs in peritoneal carcinomatosis, which shows lower expression of GPR4 and GPR68 as compared to other pH-GPCRs in this type of cancer. It may give rise to future therapies targeting either the TME or these GPCRs directly.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Journal of Clinical Medicine | ||||
| Verlag: | MDPI | ||||
|---|---|---|---|---|---|
| Ort der Veröffentlichung: | BASEL | ||||
| Band: | 12 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 5 | ||||
| Seitenbereich: | S. 1803 | ||||
| Datum | 23 Februar 2023 | ||||
| Institutionen | Medizin > Lehrstuhl für Chirurgie Medizin > Lehrstuhl für Dermatologie und Venerologie Medizin > Lehrstuhl für Pathologie Medizin > Zentren des Universitätsklinikums Regensburg > Zentrum für Klinische Studien | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | PROTEIN-COUPLED RECEPTOR; TUMOR-GROWTH; TDAG8; MIGRATION; GENE; OVEREXPRESSION; PROLIFERATION; INVOLVEMENT; METASTASIS; INHIBITION; colorectal; peritoneal carcinomatosis; tumor microenvironment | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-538993 | ||||
| Dokumenten-ID | 53899 |
Downloadstatistik
Downloadstatistik